Full Analysis capability
Thin Film Coating Lab
Cas No.: 147098-20-2
Bis-[(E)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]-pyrimidin-5-yl](3R,5S )-3,5-dihydroxyhept-6-enoic acid] calcium salt (2:1)
Calcium bis[(3R,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methyl-ethyl)-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]-3, 5-dihydroxyhept-6-enoate]
Shading, sealed, kept in a cool (≤25 ° C) dry place
White or off-white powder, odorless, bitter;
1. It is suitable for the adjuvant treatment of patients with primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia) or mixed lipemia (type IIb) when dieting or exercise therapy is not ideal.
2, this product can reduce elevated LDL-cholesterol, total cholesterol, triglycerides and ApoB, increase HDL-cholesterol.
3. It is also suitable for patients with homozygous familial hypercholesterolemia, which can be used alone or in combination with diet or other lipid-lowering methods (such as LDL removal).